0000950103-24-000429.txt : 20240108 0000950103-24-000429.hdr.sgml : 20240108 20240108161829 ACCESSION NUMBER: 0000950103-24-000429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DALOIA G PETER CENTRAL INDEX KEY: 0001210413 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38694 FILM NUMBER: 24520377 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Livent Corp. CENTRAL INDEX KEY: 0001742924 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 824688610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1818 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-299-5900 MAIL ADDRESS: STREET 1: 1818 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: FMC Lithium USA Holding Corp. DATE OF NAME CHANGE: 20180606 4 1 dp204997_4-daloia.xml FORM 4 X0508 4 2024-01-04 1 0001742924 Livent Corp. LTHM 0001210413 DALOIA G PETER C/O LIVENT CORPORATION 1818 MARKET STREET, SUITE 2550 PHILADELPHIA PA 19103 1 0 0 0 0 Common Stock 2024-01-04 4 D 0 100985 D 0 D Common Stock 2024-01-04 4 D 0 61479 D 0 D Common Stock 2024-01-04 4 D 0 44716 D 0 I As trustee Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). Represents the conversion of each share of Livent Common Stock, held by the reporting person as of January 4, 2024 as trustee, into the right to receive a number of Arcadium Shares equal to the Merger Exchange Ratio (as defined in the Transaction Agreement). /s/ Sara Ponessa, as attorney-in-fact 2024-01-08